Home › Brain Tumors › Wisconsin › Madison
Brain Tumors clinical trials in Madison, WI
6 studies for Brain Tumors are looking for participants at sites in and around Madison (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RecruitingPhase 2
- University of Wisconsin Carbone Cancer Center, Madison
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
RecruitingPhase 2
- Local Institution - 0134, Madison
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
RecruitingPhase 2
- UW Carbone Cancer Center, Madison
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RecruitingPhase 2
- University of Wisconsin Carbone Cancer Center, Madison
18F-FLUC PET/MR in Patients With Brain Mets
RecruitingPhase 3
- University of Wisconsin, Madison
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
RecruitingPhase 2
- University of Wisconsin, Madison
About Brain Tumors
A brain tumor is a growth of abnormal cells in the brain tissue. Learn the types of tumors, symptoms, how they are diagnosed and treatment options.
More about Brain Tumors on MedlinePlus
Brain Tumors trials in other cities
- Houston, TX37 studies
- Boston, MA29 studies
- New York City, NY25 studies
- Washington, DC21 studies
- Los Angeles, CA17 studies
- Durham, NC15 studies
- Miami, FL14 studies
- Chicago, IL12 studies
- Rochester, MN12 studies
- St. Louis, MO12 studies
- Cleveland, OH11 studies
- Columbus, OH11 studies
Other studies in Madison
- Prostate Cancer29 studies
- Breast Cancer22 studies
- Colorectal Cancer22 studies
- Metastatic Cancer20 studies
- Acute Myeloid Leukemia17 studies
- Melanoma15 studies
- Non-Small Cell Lung Cancer14 studies
- Cancer (all types)14 studies
- Ovarian Cancer14 studies
- Lung Cancer11 studies
- Stomach Cancer11 studies
- Pancreatic Cancer9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.